@FierceBiotech: Join what is probably one of the fastest-growing LinkedIn groups in biotech, & learn the meaning of life... sciences. Join now | Follow @FierceBiotech
@JohnCFierce: Man, oh man. Bluebird IPO busts out, raises $101M as biotech offerings turn red hot - $BLUE up 50%. News | Follow @JohnCFierce
@RyanMFierce: W/ $BLUE out, DMD drug developer Prosensa moves up in the biotech IPO queue, sets terms for $60M deal: More | Follow @RyanMFierce
@EmilyMFierce: This week's issue of FierceBiotechResearch is out: Alzheimer's drug restores links in brain and more: This week's news | Follow @EmilyMFierce
> San Diego-based Nektar reported positive top-line results from a human abuse liability study for NKTR-181, a first-in-class, opioid analgesic molecule with a slow rate of entry into the brain. Release
> Copenhagen-based ALK says it reaped positive top-line results from the pivotal MERIT trial conducted with ALK's allergy immunotherapy tablet against house dust mite allergy. Release
> The experimental daratumumab--being developed by Genmab and Janssen--scored a durable response against multiple myeloma in a Phase I study. Report (reg. req.)
@FierceMedDev: Editor's Corner: Germany's Epigenomics is betting its future on an early-detection colon cancer Dx. Feature | Follow @FierceMedDev
@DamianFierce: Medtronic's Infuse no better than graft procedure but more dangerous, according to independent reviews. Yesterday's story | Follow @DamianFierce
> Techne grabs Bionostics for $104M. Item
> Terumo adding 400+ jobs in R&D expansion. Report
> CryoLife eyes FDA approval for dissolving hemostat. Item
> Mirabilis nabs up to $13M for uterine fibroid device. Report
> OrthoSensor wins FDA nod for knee tech. Article
Pharma News
@FiercePharma: More Novo Nordisk bad news: Loses Prandin patent fight in U.S. Circuit court, $200m sales at risk. Report | Follow @FiercePharma
@EricPFierce: U.K. gets nervous on looming deadline for API certifications, outlines contingency plan. Yesterday's report | Follow @EricPFierce
> Biogen's impressive Tecfidera launch hits reimbursement, supply snags. Article
> Onglyza fails outcomes trial in a $1B hit for Bristol-Myers, AstraZeneca. Story
> Use prescription meds properly, save $200 billion a year. Report
Drug Delivery News
@MichaelGFierce: Self-propelled, spinning 'nano-necklaces' could pinpoint drug delivery. More | Follow @MichaelGFierce
> BD, JDRF partner to join artificial pancreas race. More
> Capsugel launches Lipidex platform for greater oral stability, potency. Item
> Teva grabs MicroDose respiratory biz with inhaled delivery platform. Article
> Drug-carrying 'nanovolcanoes' make precise delivery structures. Story
And Finally… Investigators say that a new study proves that an adequate amount of sleep reduces the risk of diabetes. Release